StockData
OGINasdaqPharmaceutical PreparationsFiscal year ends September 30

ORGANIGRAM GLOBAL INC.

Financials through fiscal 2025, year ended Sep 30, 2025Last filing: 40-F on Dec 16, 2025
$0.94+0.02 (+1.73%)

Close on Oct 19, 2026

ORGANIGRAM GLOBAL INC. income statement

Ratios

Latest available, balances at Sep 30, 2025

Profitability, FY2025

Gross margin
34.8%
Operating margin
-5.9%
Net margin
–
Return on equity, FY2025
–

Financial strength

Current ratio
2.26
Debt to equity
–
Debt to assets
0.0%
Cash to current liabilities
66.3%

Valuation

P/E ratio
–
Price to sales
–
Price to book
–
Dividend yield
–

Valuation ratios need the share price and fill in once daily prices are connected.